Related Experiment Video
Updated: Aug 8, 2025

09:47
Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
Published on: December 15, 2023
1.2K
Deep belief network-based approach for detecting Alzheimer's disease using the multi-omics data.
Nivedhitha Mahendran1, Durai Raj Vincent P M1
1School of Information Technology and Engineering, Vellore Institute of Technology, Vellore, India.
Computational and Structural Biotechnology Journal
|March 6, 2023
Summary
This study introduces a novel Deep Belief Network model for predicting Alzheimer's disease (AD) risk using multi-omics data. The advanced feature selection method effectively addresses high-dimensional data challenges, improving prediction accuracy for dementia risk factors.
Area of Science:
- Bioinformatics
- Genomics
- Neuroscience
Background:
- Alzheimer's disease (AD) mechanisms remain poorly understood, with limited identification of genetic risk factors.
- Past research relied heavily on brain imaging, lacking robust genetic analysis techniques.
- Advancements in high-throughput bioinformatics enable focused research into AD-associated genetic risk factors.
Purpose of the Study:
- To develop a Deep Belief Network (DBN) based prediction model for Alzheimer's disease.
- To address High-Dimension Low Sample Size (HDLSS) challenges in genomic and epigenomic data.
- To identify reliable genetic risk factors for Alzheimer's disease using multi-omics data.
Main Methods:
- Utilized DNA Methylation and Gene Expression Microarray Data.
- Implemented a two-layer feature selection approach: identifying differentially expressed/methylated features and combining datasets via Jaccard similarity.
- Applied an ensemble-based feature selection method and a Deep Belief Network for prediction.
Main Results:
- The proposed two-layer feature selection method outperformed Support Vector Machine Recursive Feature Elimination (SVM-RFE) and Correlation-based Feature Selection (CBS).
- The Deep Belief Network model demonstrated superior performance compared to widely used Machine Learning models.
- Multi-omics data integration yielded more promising results than single-omics approaches for AD prediction.
Conclusions:
- The developed feature selection and Deep Belief Network model offer a promising approach for identifying Alzheimer's disease genetic risk factors.
- Multi-omics data integration is effective in enhancing prediction accuracy for complex neurological disorders like AD.
- This study provides a foundation for improved diagnostic and predictive tools for Alzheimer's disease.
Related Concept Videos
Alzheimer's Disease: Overview
575
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
575
Alzheimer's Disease: Treatment
233
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
233

